Loading clinical trials...
Loading clinical trials...
Determining Biomechanical and Morphological Factors That Affect Children With Duchenne Muscular Dystrophy (DMD) Who Loss of the Ability to Walk
Conditions
Interventions
No drug and no placebo were used in this study
Locations
10
France
CHRU
Brest, Brittanny, France
CHRU
Lille, North, France
CHRU
Angers, France
CH Le Mans
Le Mans, France
CHU
Lyon, France
CHU de Nantes
Nantes, France
Start Date
July 1, 2015
Primary Completion Date
January 1, 2020
Completion Date
January 1, 2021
Last Updated
March 16, 2018
Lead Sponsor
University Hospital, Brest
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions